Cabaletta Bio Inc. (CABA)
CABA trades on Nasdaq in Health Care, Biotechnology: Biological Products (No Diagnostic Substances). Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.69
-5.59% on the day
Market cap
$286.5M
Micro cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | CABA on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Country | United States |
| IPO year | 2019 |
| SEC CIK | 0001759138 |
| SEC industry code | Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
Financials
Not reported in SEC XBRL data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-05-04 |
| Latest annual report | 10-K | 2026-03-23 |
| Latest quarterly / interim | 10-Q | 2026-08-13 |
| Latest current report | 8-K | 2026-09-14 |
| Latest proxy | DEFA14A | 2026-06-01 |
Source: SEC EDGAR submissions feed, 444 recent filings. All filings on EDGAR.
Peers in Biotechnology: Biological Products (No Diagnostic Substances)
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| SRZN | Surrozen Inc. | $23.51 | -5.05% | $276.3M |
| OCGN | Ocugen Inc. | $0.8854 | -6.52% | $300.2M |
| IRLA | IRulya Therapeutics Inc. | $27.87 | -13.98% | $302.2M |
| ARTV | Artiva Biotherapeutics Inc. | $6.29 | -7.09% | $307.5M |
| AGEN | Agenus Inc. | $6.95 | -6.46% | $313.9M |
| XFOR | X4 Pharmaceuticals Inc. | $2.60 | -7.80% | $257.8M |
| PALI | Palisade Bio Inc. | $1.47 | -7.86% | $255.3M |
| IPSC | Century Therapeutics Inc. | $1.38 | -4.17% | $249.9M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier